Delivery Order SPE2DB25D3018-SPE2DB25FUYLA
- Not listed
- The Defense Logistics Agency awarded a $18,415.47 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a direct delivery of pharmaceutical products to support federal healthcare operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $110,776.11 for Dupixent 300 mg/2 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal pharmaceutical supply needs. The contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $35,928.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-set-aside contract was awarded competitively and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $12,356.56 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price contract, which received no set-aside designation, leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,400.47 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,709.46 on August 12, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,091.93 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the vendor's corporate headquarters location in...
- The Defense Logistics Agency awarded a $43,038.15 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dupixent 300 mg/2 mL pens with an ultimate completion date of August 11, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $15,036.39 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 ml pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award reflects the agency's ongoing procurement of specialty pharmaceutical products to support military...
- The Defense Logistics Agency awarded a delivery order valued at $47,262.06 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete openly for...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYLADelivery Order
The Defense Logistics Agency awarded a $37,235.93 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens to be completed by September 2, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The IDC structure provides flexibility for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to issue delivery orders for needed pharmaceutical products as requirements arise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 8/29/25 |